Form 4: AN2 Therapeutics CFO Lucy Day Reports Acquisition of Stock Options and Restricted Stock Units

Lucy Day, CFO of AN2 Therapeutics, reports the acquisition of stock options and restricted stock units (RSUs) in the company.

Summary

• On February 26, 2025, Lucy Day, the Chief Financial Officer of AN2 Therapeutics, acquired 46,500 shares of common stock.
• These shares were received as restricted stock units (RSUs).
• Ms. Day also acquired options to purchase 93,000 shares of common stock at an exercise price of $1.13.
• Following these transactions, Ms. Day beneficially owns 79,170 shares of common stock and options for 93,000 shares.
• The RSUs vest over three to four years from January 1, 2025, contingent upon continued service to the company.
• The stock options vest monthly over four years from January 1, 2025, also contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of shares and options by the CFO can be seen as a positive sign, but it's not necessarily indicative of significant future performance.

Positives

• The acquisition of stock options and RSUs by the CFO aligns her interests with those of the shareholders.
• The vesting schedules of the RSUs and stock options incentivize continued service and commitment to the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests and assess management's confidence in the company's future prospects.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of compensation for executives in the biotechnology industry.
• Vesting schedules of three to four years are typical for such grants, aligning executive compensation with long-term company performance.
• The size of the grant should be compared to grants made to executives at peer companies to determine if it is in line with industry standards.

Stakeholder Impact

• Shareholders may view the acquisition of stock options and RSUs by the CFO as a positive sign, aligning her interests with theirs.
• Employees may be motivated by the fact that the CFO is incentivized to improve the company's performance.

Key Dates